- Home
- PBYI vs PEBK Comparison
PBYI vs PEBK Comparison
Compare PBYI & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- PEBK
- Stock Information
- Founded
- PBYI 2010
- PEBK 1912
- Country
- PBYI United States
- PEBK United States
- Employees
- PBYI N/A
- PEBK N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- PEBK Major Banks
- Sector
- PBYI Health Care
- PEBK Finance
- Exchange
- PBYI Nasdaq
- PEBK Nasdaq
- Market Cap
- PBYI 167.3M
- PEBK 148.4M
- IPO Year
- PBYI N/A
- PEBK N/A
- Fundamental
- Price
- PBYI $3.24
- PEBK $27.84
- Analyst Decision
- PBYI Strong Buy
- PEBK
- Analyst Count
- PBYI 1
- PEBK 0
- Target Price
- PBYI $7.00
- PEBK N/A
- AVG Volume (30 Days)
- PBYI 347.1K
- PEBK 6.9K
- Earning Date
- PBYI 07-31-2025
- PEBK 07-21-2025
- Dividend Yield
- PBYI N/A
- PEBK 3.39%
- EPS Growth
- PBYI 143.51
- PEBK 4.04
- EPS
- PBYI 0.77
- PEBK 3.05
- Revenue
- PBYI $232,709,000.00
- PEBK $83,033,000.00
- Revenue This Year
- PBYI N/A
- PEBK N/A
- Revenue Next Year
- PBYI N/A
- PEBK N/A
- P/E Ratio
- PBYI $4.40
- PEBK $9.08
- Revenue Growth
- PBYI 2.68
- PEBK 7.01
- 52 Week Low
- PBYI $2.23
- PEBK $23.74
- 52 Week High
- PBYI $4.13
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- PBYI 50.17
- PEBK 47.99
- Support Level
- PBYI $3.38
- PEBK $27.41
- Resistance Level
- PBYI $3.70
- PEBK $28.25
- Average True Range (ATR)
- PBYI 0.18
- PEBK 0.58
- MACD
- PBYI -0.03
- PEBK -0.05
- Stochastic Oscillator
- PBYI 35.82
- PEBK 34.67
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.